There is almost no chance that the first interim look will lead to some type of placebo to treatment arm crossover. The OS numbers needed IMO simply aren't mature enough at this point in the trial to drive a statistically significant action like that. It's sad, but because of that lab rat in Fargo there are hundreds of people dying sooner than needed in the SUNRISE trial.
Eric I was being sarcastic to Roy, follow the posts. Myself I just expect the DMC to green light the first look in. Wall Street is anxiously waiting also.
As for my tweet campaign tommorow that was not my idea but rather Dr. Michael Fisch whose a friend and investor in PPHM and going to ASCO. He has 9k followers on Twitter. Since he favorited my article I've gotten 3k more reads he now follows me on Twitter.
News 
Market Data 
Discover 
AI
